Advanced Imaging for Radiation Planning in Non-Small Cell Lung Cancer

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 1

Waitlist Available

Sponsor: Xemed LLC

No Placebo Group

Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?

This trial uses advanced imaging to help treat lung cancer patients. It aims to protect healthy lung tissue while effectively targeting the tumor.

Do I need to stop my current medications for this trial?

The trial protocol does not specify if you need to stop taking your current medications. However, since the trial involves MRI scans, you should inform the study team about all medications you are taking, as some might interact with the imaging process.

What data supports the idea that Advanced Imaging for Radiation Planning in Non-Small Cell Lung Cancer is an effective treatment?

The available research shows that Hyperpolarized Xenon-129 MRI is a promising tool for lung imaging, particularly in assessing lung function and ventilation. Although most studies focus on non-cancerous lung diseases, the ability to evaluate key lung processes suggests potential benefits for lung cancer patients. The research highlights its unique capability to provide detailed 3D images of lung function, which could improve treatment planning for lung cancer. However, there is no direct comparison to other treatments for lung cancer in the provided data. ^{1 2 3 4 5}

What safety data exists for Hyperpolarized Xenon-129 MRI?

The safety and tolerability of Hyperpolarized Xenon-129 MRI have been assessed in various studies, primarily focusing on non-malignant pulmonary diseases and pediatric lung function. The research indicates that it is a promising imaging modality, but its safety in specific populations, such as children with cystic fibrosis, has not been rigorously assessed. Overall, it is considered a noninvasive diagnostic tool with potential applications in lung imaging. ^{1 3 5 6 7}

Is Hyperpolarized Xenon-129 MRI a promising treatment for lung cancer?

Yes, Hyperpolarized Xenon-129 MRI is a promising treatment for lung cancer because it helps doctors see how well the lungs are working and can guide radiation therapy to avoid damaging healthy lung areas. ^{1 2 3 5 8}

Research Team

Eligibility Criteria

This trial is for adults over 18 with non-small cell lung cancer who are set for radiation therapy. It's also open to those with severe COPD or a history of successful prior lung cancer treatment and now facing secondary lung cancer. Exclusions include pregnancy, inability to consent, unstable living situations, substance dependence, large body size or chest that won't fit in an MRI machine, metal implants, and certain health conditions.

Inclusion Criteria

I had successful radiation for lung cancer and now have a second lung cancer.

I have new lung cancer and severe COPD, and am planned for radiation therapy.

I am over 18 and diagnosed with non-small lung cancer, scheduled for radiation therapy.

Exclusion Criteria

You have a metal device implanted in your body.

A language, communication, cognitive or behavioral impairment that might interfere with fully informed participation in the study

If you have any reason that makes it unsafe for you to have an MRI scan.

Treatment Details

Interventions

• Hyperpolarized Xenon-129 MRI (Radiation Therapy)

Trial Overview The study tests hyperpolarized xenon-129 MRI's ability to map healthy vs compromised lung tissue in patients undergoing radiation therapy for lung cancer. The goal is to tailor treatment plans that minimize damage to functioning lungs and reduce the risk of radiation pneumonitis.

Participant Groups

Group I: Standard-of-care Radiation Therapy for lung cancer using HXe MRI for diagnosis. Experimental Treatment 1 Intervention

Patients with non-small cell lung cancer scheduled for radiation therapy will be voluntarily enrolled in this study, where they will have their lung ventilation and function imaged with hyperpolarized xenon MRI. The 3D HXe images will be used in determining a functional lung avoidance treatment map. However, for this part of the study, subjects will still follow the standard-of-care radiation treatment plan. At 6-month follow up the subjects will be imaged again with HXe to assess lung ventilation and function post-RT compared to baseline (pre-RT). Additionally, standard-of-care lung testing (DLCO, PFT) and quality-of-life questionnaires will be assessed at several time points during the study.

Group II: Guided Radiation Therapy for lung cancer using HXe MRI for functional lung avoidance and diagnosis. Experimental Treatment 1 Intervention

Patients with non-small cell lung cancer scheduled for radiation therapy will be voluntarily enrolled in this study. They will have their lung ventilation and function imaged with hyperpolarized xenon MRI. The 3D HXe images will be used in determining a functional lung avoidance treatment map. Patients will follow radiation therapy optimized for functional lung avoidance. At 6-month follow up the subjects will be imaged again with HXe to assess lung ventilation and function post-RT compared to baseline (pre-RT). Additionally, standard-of-care lung testing (DLCO, PFT) and quality-of-life questionnaires will be assessed at several time points during the study.

Who Is Running the Clinical Trial?

Xemed LLC

Lead Sponsor

Trials

8

Recruited

370+

University of Pennsylvania

Collaborator

Trials

2,118

Recruited

45,270,000+

Dr. Joan Lau

University of Pennsylvania

Chief Executive Officer since 2020

PhD in Neuroscience from the University of Cincinnati College of Medicine, MBA from the Wharton School of Business, BS in Bioengineering from the University of Pennsylvania

Dr. Robert Iannone

University of Pennsylvania

Chief Medical Officer since 2019

MD from Yale University, MSCE from the University of Pennsylvania

Findings from Research

The continuous flow-type hyperpolarizing (CF-HP) system allows for effective lung imaging using hyperpolarized (129)Xe MRI at very low concentrations of xenon, minimizing the anesthetic effects and reducing xenon consumption.

Using a 70% xenon gas mixture resulted in better signal-to-noise ratios for both gas and dissolved-phase images compared to a 3% mixture, although the apparent diffusion coefficient (ADC) was higher with the 3% mixture, indicating a complex relationship between concentration and imaging quality.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Hyperpolarized 129 Xe MRI of the mouse lung at a low xenon concentration using a continuous flow-type hyperpolarizing system. Wakayama, T., Kitamoto, M., Ueyama, T., et al.[2015]

Hyperpolarized 129Xe MRI is a new imaging technique that allows for detailed lung imaging and can also detect 129Xe in the brain, providing insights into brain parenchyma and blood vessels.

The study outlines specific protocols for using 129Xe MRI in both rodents and humans, highlighting its potential for advanced medical imaging applications.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Brain Imaging Using Hyperpolarized 129Xe Magnetic Resonance Imaging. Chahal, S., Prete, BRJ., Wade, A., et al.[2019]

Hyperpolarized 129Xe gas is safe and well-tolerated as an inhaled contrast agent for MRI in children, with no serious adverse events reported during the study involving 28 participants aged 6 to 16 years.

While some children experienced mild and temporary changes in oxygen saturation and heart rate after inhalation, these effects were consistent with expected physiological responses and resolved quickly, indicating that 129Xe MRI is feasible for assessing lung function in pediatric patients.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Feasibility, tolerability and safety of pediatric hyperpolarized 129Xe magnetic resonance imaging in healthy volunteers and children with cystic fibrosis. Walkup, LL., Thomen, RP., Akinyi, TG., et al.[2022]

Hyperpolarized (HP) noble gases like (3)He and (129)Xe are emerging as noninvasive contrast agents for MRI, particularly useful in diagnosing pulmonary diseases.

Recent advancements in HP (129)Xe MR measurements have enhanced our ability to study lung dysfunctions in mice, paving the way for potential applications in human diagnostics.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Small animal imaging with hyperpolarized 129Xe magnetic resonance. Imai, H., Kimura, A., Fujiwara, H.[2019]

In a pilot study involving 10 patients with non-small cell lung cancer, using hyperpolarized xenon-129 MRI for radiotherapy planning was shown to be feasible and effective in identifying well-ventilated lung areas.

The function-based radiotherapy plan (Plan-F) significantly reduced radiation exposure to well-ventilated lung regions compared to the standard anatomic plan (Plan-A), indicating a potential strategy to minimize radiation-induced lung injury.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

A pilot study of function-based radiation therapy planning for lung cancer using hyperpolarized xenon-129 ventilation MRI. Ding, Y., Yang, L., Zhou, Q., et al.[2022]

References

1. Australia pubmed.ncbi.nlm.nih.gov

Functional airway obstruction observed with hyperpolarized 129 Xenon-MRI. [2022]

2. Ireland pubmed.ncbi.nlm.nih.gov

The role of hyperpolarized 129xenon in MR imaging of pulmonary function. [2018]

3. United States pubmed.ncbi.nlm.nih.gov

Hyperpolarized 129 Xe MRI of the mouse lung at a low xenon concentration using a continuous flow-type hyperpolarizing system. [2015]

4. Ireland pubmed.ncbi.nlm.nih.gov

Pulmonary hyperpolarized noble gas MRI: recent advances and perspectives in clinical application. [2017]

5. United States pubmed.ncbi.nlm.nih.gov

Brain Imaging Using Hyperpolarized 129Xe Magnetic Resonance Imaging. [2019]

6. Germany pubmed.ncbi.nlm.nih.gov

Feasibility, tolerability and safety of pediatric hyperpolarized 129Xe magnetic resonance imaging in healthy volunteers and children with cystic fibrosis. [2022]

7. Switzerland pubmed.ncbi.nlm.nih.gov

Small animal imaging with hyperpolarized 129Xe magnetic resonance. [2019]

8. United States pubmed.ncbi.nlm.nih.gov

A pilot study of function-based radiation therapy planning for lung cancer using hyperpolarized xenon-129 ventilation MRI. [2022]